Bayer Balance Sheet Health
Financial Health criteria checks 2/6
Bayer has a total shareholder equity of €35.8B and total debt of €46.3B, which brings its debt-to-equity ratio to 129.4%. Its total assets and total liabilities are €119.9B and €84.1B respectively. Bayer's EBIT is €7.9B making its interest coverage ratio 9.7. It has cash and short-term investments of €4.7B.
Key information
129.4%
Debt to equity ratio
€46.27b
Debt
Interest coverage ratio | 9.7x |
Cash | €4.73b |
Equity | €35.76b |
Total liabilities | €84.12b |
Total assets | €119.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BAYN's short term assets (€40.2B) exceed its short term liabilities (€30.6B).
Long Term Liabilities: BAYN's short term assets (€40.2B) do not cover its long term liabilities (€53.5B).
Debt to Equity History and Analysis
Debt Level: BAYN's net debt to equity ratio (116.2%) is considered high.
Reducing Debt: BAYN's debt to equity ratio has increased from 84.8% to 129.4% over the past 5 years.
Debt Coverage: BAYN's debt is not well covered by operating cash flow (14.1%).
Interest Coverage: BAYN's interest payments on its debt are well covered by EBIT (9.7x coverage).